FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals and CRISPR Therapeutics could
2023-11-01 07:58
US FDA approves Regeneron's ultra-rare blood disease drug
(Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its drug to treat a rare blood disease. The
2023-08-19 02:24
US Supreme Court to scrutinize Purdue Pharma bankruptcy settlement
By John Kruzel and Andrew Chung WASHINGTON (Reuters) -The U.S. Supreme Court on Thursday agreed to hear a challenge by
2023-08-11 04:17
Teva agrees to pay $126 million to US hospitals over opioids
By Brendan Pierson Teva Pharmaceutical Industries Ltd has agreed to pay up to $126 million to U.S. hospitals
2023-08-04 00:53
Nvidia invests $50 million in Recursion to train AI models for drug discovery
(Reuters) -Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which
2023-07-12 20:52
US FDA approves BioMarin's gene therapy for hemophilia A
By Nathan Gomes (Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical's gene therapy for hemophilia A,
2023-06-30 04:28
Teva to pay Nevada $193 million over role in opioid epidemic
By Brendan Pierson Teva Pharmaceutical Industries on Wednesday agreed to pay Nevada $193 million to settle claims that
2023-06-08 05:25
US doctors forced to ration as cancer drug shortages hit nationwide
One woman denied a chemotherapy drug compared the situation to "triage on the battlefield".
2023-06-08 02:29
Purdue Pharma can protect Sackler owners in opioid bankruptcy, court rules
By Dietrich Knauth NEW YORK Bankrupt OxyContin maker Purdue Pharma can shield its owners, members of the wealthy
2023-05-30 22:52
U.S. FDA approves Lexicon Pharma's heart failure drug
(Reuters) -The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc's drug as a broad treatment for heart
2023-05-27 04:54
Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
By Ludwig Burger FRANKFURT Zealand Pharma and partner Boehringer Ingelheim said their experimental obesity drug achieved up to
2023-05-10 15:58